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Abstract
Background: Prevention of depression must address multiple risk factors. Estimating overall risk
across a range of putative risk factors is fundamental to prevention of depression. However, we
lack reliable and valid methods of risk estimation. This protocol paper introduces PREDICT, an
international research study to address this risk estimation.
Methods/design: This is a prospective study in which consecutive general practice attendees in
six European countries are recruited and followed up after six and 12 months. Prevalence of
depression is assessed at baseline and each follow-up point. Consecutive attendees between April
2003 and September 2004 who were aged 18 to 75 were asked to take part. The possibility of a
depressive episode was assessed using the Depression Section of the Composite International
Diagnostic Interview. A selection of presumed risk factors was based on our previous work and a
systematic review of the literature. It was necessary to evaluate the test-retest reliability of a
number of risk factor questions that were developed specifically, or adapted, for the PREDICT
study. In a separate reliability study conducted between January and November 2003, consecutive
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BMC Public Health 2006, 6:6 http://www.biomedcentral.com/1471-2458/6/6general practice attendees in the six participating European countries completed the risk factor
items on two occasions, two weeks apart. The overall response rate at entry to the study was 69%.
We exceeded our expected recruitment rate, achieving a total of 10,048 people in all. Reliability
coefficients were generally good to excellent.
Discussion: Response rate to follow-up in all countries was uniformly high, which suggests that
prediction will be based on almost a full cohort. The results of our reliability analysis are
encouraging and suggest that data collected during the course of PREDICT will have a satisfactory
level of stability. The development of a multi-factor risk score for depression will lay the foundation
for future research on risk reduction in primary care. Our data will also provide the necessary
evidence base on which to develop and evaluate interventions to reduce the prevalence of
depression.
Background
Depression will rank second to cardiovascular disease as a
global cause of disability by 2020 [1]. It occurs in up to a
quarter of general practice attendees [2,3], relapse is fre-
quent up to 10 years from first presentation [4-6] and
residual disability is common [7]. Prevalence is deter-
mined by exposure to risk factors that precipitate or main-
tain episodes of disorder. The two most consistently
identified risk factors are low socio-economic status [8-
10] and female sex [11]. Relative poverty and unemploy-
ment are associated with longer duration of episodes of
depression rather than their onset [10,12]. Socio-eco-
nomic risk factors that might conceivably be addressed
include low income and financial strain [10,13], unem-
ployment [10], work stress [14], social isolation [14,15],
and poor housing [9]. Fixed factors such as a family his-
tory of depression [12] and personality play a part [16]
but it is not yet known whether they act independently of
other risk factors.
Prevention of depression must address multiple risk fac-
tors [17], include those at low and moderate risk [18] and
be acceptable to the target population [19]. However, in
contrast to physical disorders such as cardiovascular dis-
ease, many mutable risk factors affect the duration of epi-
sodes of depression, rather than simply their onset [20].
Estimating overall risk across a range of putative risk fac-
tors is fundamental to prevention of depression. How-
ever, we lack reliable and valid methods of risk estimation
[21].
The PREDICT study is taking place in six European and
one Latin American country in order to test the following
hypotheses: 1) A reliable and valid multi-factor scale can
be developed to determine the risk for the onset and
maintenance of depression in primary care attendees; and
2) The overall risk equation derived from data for all
countries combined will have similar accuracy in predict-
ing episodes of depression for each country. In this intro-
ductory paper, we describe the method, response rates at
baseline and first follow-up and the reliability of instru-
ments developed or adapted for the study.
Methods/design
Design
This is a prospective study in which consecutive general
practice attendees are recruited and followed up after six
and 12 months. Prevalence of depression is assessed at
baseline and each follow-up point. The study was
approved by the relevant ethical committees in each coun-
try.
Setting
Six European and one Latin American centre are partici-
pating: 1) 25 general practices in the Medical Research
Council's General Practice Research Framework, distrib-
uted across the United Kingdom; 2) nine large primary
care centres in Andalucía, Southern Spain; 3) 74 general
practices distributed nationwide in Slovenia; 4) 23 gen-
eral practices distributed nationwide in Estonia; 5) seven
large general practice centres near Utrecht, The Nether-
lands; 6) two large primary care centres in urban and rural
areas of Portugal that include 25 general practitioners;
and 7) 78 general practices in Chile. The general practices
taking part extend over urban and rural settings in each
country and populations with considerable socio-eco-
nomic and ethnic variation.
Sample
Consecutive attendees between April 2003 and September
2004 who were aged 18 to 75 were asked to take part.
Those over 75 were excluded because prevalence of cogni-
tive impairment increases after that age. Other exclusion
criteria were an inability to understand one of the princi-
pal languages involved, severe organic mental illness and
terminal illness. Participants who gave informed consent
subsequently undertook an interview at their home or the
general practice within two weeks. Because of local service
preferences the recruitment approach was slightly differ-
ent in each country. In the UK and the Netherlands,
researchers approached patients waiting to see the doctor,Page 2 of 8
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the research first before the researcher was introduced.
Measures of outcome and exposure
Depression
The possibility of a depressive episode was assessed using
the Depression Section of the Composite International
Diagnostic Interview (CIDI) [22,23], which provides six
month and lifetime psychiatric diagnoses according to
ICD10 and DSMIV.
Risk factors for the depression
Selection of presumed risk factors was based on our previ-
ous work [24,25] and a systematic review of the literature.
Where possible, we used published self-report measures
of established reliability and validity. In some instances,
questions were developed for the study or adapted from
available standardised instruments. We addressed risk fac-
tors that are intrinsic either to the individual or to the
social context, while remaining aware that there is inevita-
ble overlap in such a categorisation. The risk factors in ital-
ics were assessed for test-retest reliability (see below).
• Socio-demographic factors.
• A lifetime history of depression (assessed by CIDI at
baseline).
• Controls, demands and rewards for unpaid work using an
adapted version of the job content instrument [26].
• Debt and financial strain [10].
• Consultation rate in the general practice [27].
• Self-rated physical health problems and limiting long-
term disability using the Short Form 12, a brief, self-report
disability schedule that has application across a number
of cultures [28]
• Alcohol misuse using the WHO's AUDIT questionnaire
[29]
• Use of recreational drugs adapted from the relevant sections
of the CIDI.
• Brief questions on cigarette consumption
• For women, questions on menstruation, pregnancy and
childbirth from the Patient Health Questionnaire (PHQ)
[30].
• Brief questions on the quality of sexual and emotional rela-
tionships adapted from a standardized questionnaire [31].
• Problems in people close to participants [32].
• Childhood experiences of physical, emotional and sex-
ual abuse [33]
• Nature and strength of spiritual beliefs [34].
• Family psychiatric history: depression in first-degree family
members requiring pharmacological or psychological treatment
in primary or secondary care. Suicide in first degree relatives
[35].
• Anxiety symptoms using the anxiety section of the PHQ
[30].
• One question on whether or not, and at what age, the
participant had lost one or both parents by death.
• Household type and composition.
• The living environment including satisfaction with neigh-
bourhood and perception of safety inside/outside of the home,
using questions from the Health Surveys for England [36].
• Threatening life events in the preceding six months,
using a brief validated checklist [37].
• Experiences of discrimination based on a recent European
study [38].
• Adequacy, availability and sources of social support
[39].
Assessment of test-retest reliability
Many of the items in the PREDICT risk factor assessment
are either based on previously validated measures, or con-
cern exposures that are likely to be reported with a high
degree of reliability (e.g. age, sex, ethnicity and civil sta-
tus). However, we needed to evaluate the test-retest relia-
bility of a number of risk factor questions (noted in italics
above) that were developed specifically, or adapted, for
the PREDICT study. In a separate reliability study con-
ducted between January and November 2003, consecutive
general practice attendees in the six participating Euro-
pean countries were invited to complete the risk factor
items on two occasions, two weeks apart. At the time of
retest, we re-contacted participants (using the general
practice/health centre letterheads), reminding them of the
study. Questionnaires were completed by assisted inter-
views. Expert opinions regarding the appropriate interval
between test and retest vary from an hour to a year,
depending on the task; a test-retest interval of between
two and 14 days is usual [40]. Two weeks is sufficient time
for patients to have forgotten their first responses but for
opinions to have remained stable. We did not attempt toPage 3 of 8
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many uncertainties in choosing a standard against which
to validate patient reports of this type, and 2) patients'
reports will form the basis of the eventual risk tool.
Data quality control
Data quality was monitored to ensure that the project
yielded data of the highest validity and reliability.
Translation of instruments
We used standardised validated instruments available in
the native language of all the participant countries. In
those instances where this was not possible we translated
standardised instruments from English to the relevant lan-
guages. Where we developed our own measures, these
were also translated from English into the languages of the
participant countries. Each translation was back-trans-
lated by professional translators and the penultimate ver-
sion verified by the co-ordinating centre. No major
discrepancy was identified in any of the back-translations.
Data checking
Locally, each interview was checked for completion by the
interviewer. Quality assurance focused on the standard-
ised training of researchers in the use of the CIDI and
other questionnaires, in the recruitment and interviewing
of patients and in data management. Over and above
national team meetings a research coordinator made two
assessments of each interviewer during the baseline inter-
views to monitor the interview process, assess adherence
to the CIDI, provide structured feedback for improvement
and manage other problems as they arose. Structured and
standardised data quality control sheets are used to man-
age data and ensure its transfer to the coordinating centre
(UK). Progress reports for each national centre are submit-
ted every six months and critically assessed by the steering
group at project management meetings. Each participat-
ing country double entered 10% of its data records and
accepted a 1% error rate before deciding on full double
entry.
Statistical analysis
We calculated test-retest agreement using the kappa statis-
tic for questions with two response options and the intra-
class correlation coefficient (ICC) for items with more
than two ordinal categories. When both follow-ups are
complete we shall 1) be able to identify risk factors for
incidence of depression over six and 12 months, from par-
ticipants who were not depressed at baseline; 2) be able to
identify factors for recovery from depression over six and
12 months, from participants who were depressed at base-
line; have extra data with which to predict episodes of
depression over 6 months, by relating not only data avail-
able from baseline and 6 month time points, but also
from 6 month to 12 month time points; 3) be able to
determine time of onset and offset of episodes with
greater precision and reliability over intervals of six, rather
than 12 months; and 4) determine how incidence of, and
recovery from, depression is associated with changes in
risk factors over 6 and 12 months. We shall derive risk fac-
tor equations using logistic regression analysis on a ran-
domly chosen 50% sample (training set). We shall then
apply the equation for risk to the remaining 50% (test
set). Actual occurrence of depression during follow up
will be compared with the prediction using relative oper-
ating characteristics (ROC) curve analysis. We shall
choose the point of the ROC curve corresponding to 70%
specificity as a cut-off for estimating sensitivity for subjects
in all countries combined (and for participants in each
country) in the test set. Confidence intervals for sensitivity
in each country will indicate country heterogeneity. If esti-
mated sensitivity in a particular country is significantly
worse than overall sensitivity, and this difference is clini-
cally important, new risk factor equations will be derived
which include country specific effects. The latter can
include an allowance for differences in overall case rate, or
varying impacts of certain risk factors. We shall test the
new equation until no further reduction in heterogeneity
is possible. If after developing the best possible equation,
sensitivity is still substantially worse than 70% for any
country at the 1% significance level, a new equation will
be derived specifically for that country. We believe this is
unlikely to prove necessary, as there is no reason to sus-
pect that the model will differ across countries, given our
wealth of knowledge about risk factors.
Statistical power and sample size
At the time our sample size was calculated, Chile's partic-
ipation was not finalised and thus it was estimated on the
basis of six participating countries. A DSMIV diagnosis of
major depression will provide the primary outcome meas-
ure. Our estimate of numbers for the prospective study
was based on 1) a specificity and sensitivity of our risk
score of at least 70%; 2) an assumption of a case rate of
depression of approximately 15% and no major heteroge-
neity between centres. This requires a sample size of 2193,
which we then doubled to allow for development of the
risk factor score on one random half of the population
and testing on the other, and to allow for an attrition rate
of 30%. Thus our target recruitment was 6266 or 1044 in
each country. In evaluating test-retest reliability, we calcu-
lated item coefficients for all European countries com-
bined. We aimed to recruit at least 200 participants to
achieve an intraclass correlation coefficient (ICC) with
95% confidence intervals of ± 0.10, provided the true reli-
ability exceeds 0.58 [40].Page 4 of 8
(page number not for citation purposes)
BMC Public Health 2006, 6:6 http://www.biomedcentral.com/1471-2458/6/6Results
Response rates
The overall response rate at entry to the study was 69%,
with the lowest rates in the UK and the Netherlands and
the highest in Chile (table 1). We exceeded our expected
recruitment rate, achieving a total of 10,048 people in all.
Response rates at the six month follow-up point were very
high; 12 months follow-up is not yet complete.
Data quality
The baseline error rates for data entry in each country were
well below the 1% level of acceptability (table 2).
Test-retest reliability assessment of risk factor questions
285 general practice attendees (152 women and 133 men)
completed the questions on two occasions. Numbers in
each country ranged from 40 in Slovenia to a maximum
of 67 in the Netherlands. Their mean age was 44.6 years
(SD 16.0), which was close to the mean age of the even-
tual study population. Reliability coefficients were gener-
ally good to excellent [41,42] (table 3). Questions on
unpaid work generated kappa and ICC in the fair to good
range (0.59 to 0.70), except for one question concerning
how often participants get help and support with unpaid
work difficulties. This question also had relatively poor
percentage agreement. Five of the six questions on recent
discrimination had kappa coefficients in the fair to excel-
lent range. Responses to the sixth, concerning discrimina-
tion on the grounds of skin colour, were skewed due to
the small number of non-white participants. As a conse-
quence the kappa coefficient was low, but there was very
high percentage agreement.
Discussion
Most research into depression in primary care popula-
tions has focused on management of current disorders
rather than prediction of risk or prevention of future epi-
sodes. When our follow-up is complete we shall be able to
report on whether a risk assessment is possible in a gen-
eral practice setting. Our main results to date are 1) that
response rates to follow-up at 6 months are high and 2)
our instruments have acceptable reliability.
Setting and response rates
Our study is based on general practice attendees and not
on a probabilistic sample recruited in the community.
However, most people with depression visit their GP,
although many will not complain of depression and nor
will their mood disorder be recognized [2]. Thus the epi-
demiology of depression in general practice closely mir-
rors that seen in the community, with the caveat that
prevalence rates are higher in the former [2]. Although
Table 1: Response rates
Country Numbers 
approached
Numbers 
refused
Numbers not
eligible
Total interviewed
 at baseline
(% of eligible)
Total interviewed
6 months
(%of baseline)
UK 3319 1681 313 1325 (44%) 1144 (86%)
Spain 1470 194 6 1270 (87%) 1008 (79%)
Slovenia 1405 276 10 1119 (80%) 1036 (93%)
Estonia 1370 270 6 1094 (80%) 1025 (94%)
The Netherlands 3089 1478 390 1221 (45%) 1162 (95%)
Portugal 1552 369 3 1180 (76%) 1049 (89%)
Chile 3000 82 79 2839 (97%) 2580 (91%)
All countries 15205 4444 713 10048 (69%) 9004 (90%)
Table 2: Data entry error rates
Country Total no.
of Questionnaires
checked (A)
Total min no.
of items per
participant (B)
Total min no.
of items input
(A × B)
1% level of
input errors (A × 
B)
× 0.01
No of input
errors made
UK 131 187 24497 245 39
Spain 127 187 23749 238 32
Slovenia 112 187 20944 209 116
Estonia 110 187 20570 206 63
Netherlands 121 187 22627 226 43
Portugal 125 187 23375 234 22
Chile 2839 187 530,893 5309 2495Page 5 of 8
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Netherlands than in other countries, response rate to fol-
low-up in all countries is uniformly high, which suggests
that prediction will be based on almost a full cohort. The
lower response rate in the UK and the Netherlands may
reflect the different recruitment process we undertook in
those countries, in which the study was not so obviously
endorsed by the GP. There may also be differences in the
public's attitudes to research in those two countries, where
recruitment is generally lower across a range of research.
There were also differences in the geographical distribu-
tion of participating general practices in each country,
some being more nationally extended than in others. This
difference reflected the varying opportunities and net-
works available to the centres. We shall take account of
this variation, particularly urban-rural differences, in our
analysis of risk.
Data quality and reliability
Our data monitoring and management has ensured that
data quality reaches a high standard across the centres.
The results of our reliability analysis are encouraging and
suggest that data collected during the course of PREDICT
will have a satisfactory level of stability. Reliability
increases with sample size and thus we also know that
estimates reported here are more conservative than will be
the case in the main study. The two week period used in
this test-retest evaluation may not be equally appropriate
for all questions. For example, answers to questions on
unpaid work will have less stability over this time than
those to questions on family history of psychological dis-
order or the living environment, since satisfaction and
control at work depend on challenges and interactions
that may change daily. A question on how often partici-
pants get help and support with unpaid work difficulties
exhibited only moderate stability between test and retest
and relatively poor percentage agreement. Thus, we shall
not it include in the final analysis of prospective data. The
question on racial discrimination will be retained as its
reliability could not be assessed fairly in this data set.
Significance of the study
Depression accounts for one-fifth of all consultations
with GPs [43]. Those affected experience similar levels of
excess mortality [44] and reduced quality of life as people
with chronic physical disorders [45]. The aim of our study
is to break new ground by quantifying the future risk of
episodes of depression in primary care settings. The devel-
opment of a multi-factor risk score for depression will lay
the foundation for future research on risk reduction in pri-
mary care. Just as in prevention of cardiovascular disease
[46], effective interventions for depression will need to
address multiple risk factor domains, extend to those at
low or moderate risk and be acceptable to the target pop-
ulation. Our data will also provide the necessary evidence
base on which to develop and evaluate interventions to
reduce the prevalence of depression. In so doing up to
15% of people attending general practitioners will poten-
tially benefit by identification of their risk for episodes of
depression, with the consequent reduction of distress and
absence from work.
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